Related Experiment Video
Updated: Jul 14, 2026
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
[Polycystic ovary syndrome (PCOS)].
1Université Paris-Sud, UMR-S0782, Service de gynécologie-obstétrique et de médecine de la reproduction, hôpital Antoine-Béclère, APHP, 157, rue de la Porte-de-Trivaux, 92141 Clamart cedex, France.
Summary
Polycystic ovary syndrome (PCOS) is a common hormonal disorder affecting women, leading to reproductive, metabolic, and cardiovascular issues. Management focuses on improving insulin sensitivity, addressing hyperandrogenism, and treating infertility with various expert-guided options.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Public Health
Context:
- Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in women.
- It presents with diverse clinical manifestations impacting reproductive, metabolic, and cardiovascular health.
- Genetic factors likely contribute to androgen excess and insulin resistance, core pathophysiological elements.
Purpose:
- To outline the multifaceted nature of PCOS, including its common symptoms and associated health risks.
- To discuss emerging therapeutic strategies targeting insulin sensitivity and hyperandrogenism.
- To detail management approaches for infertility in PCOS patients, emphasizing expert care.
Summary:
- PCOS is characterized by androgen excess and insulin resistance, leading to symptoms like irregular menses, hirsutism, and infertility.
- Associated risks include glucose intolerance, type 2 diabetes, dyslipidemia, cardiovascular disease, and sleep apnea.
- Treatment strategies encompass lifestyle changes, medications to improve insulin sensitivity, hormonal therapies for hyperandrogenism, and advanced reproductive technologies for infertility.
Impact:
- Enhanced understanding of PCOS pathophysiology drives new therapeutic interventions.
- Comprehensive management can mitigate long-term metabolic and cardiovascular complications.
- Effective treatment of infertility restores reproductive potential in affected women.
Related Concept Videos
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:22Oogenesis
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...